Distribution of topiramate in a medical examiner's case

被引:18
作者
Mozayani, A [1 ]
Carter, J [1 ]
Nix, R [1 ]
机构
[1] Harris Cty Med Examiner Off, Joseph A Jachimczyk Forens Ctr, Houston, TX 77054 USA
关键词
D O I
10.1093/jat/23.6.556
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Topimarate (Topamax®) is a novel antiepileptic drug. Its mode of action is multifactorial and involves blockage of voltage-dependent sodium channels. The drug was detected in a 15-year-old epileptic who died soon after switching seizure prescriptions. Topimarate was recovered by basic extraction with ethyl acetate and analyzed by gas chromatography-mass spectrometry using selected ion monitoring: Ions monitored were m/z 324 and m/z 110 for topiramate and m/z 98 for the internal standard mepivacane. The drug was quantitated in blood, vitreous humor, bile, stomach content, and liver: the concentrations were 8.9, 12.4, and 10.9 mg/L, 31 mg/total content, and 29 mg/kg, respectively. Topiramate was detected in urine but not quantitated. Other drugs identified in this case were 0.45 mg/L nordiazepam and 0.05 mg/L oxazepam in blood. No alcohol was detected in any of the specimens. The cause of death was seizure disorder with upper respiratory infection. The manner of death was determined as natural. To our knowledge, this is the first report of the presence of topiramate in postmortem specimens.
引用
收藏
页码:556 / 558
页数:3
相关论文
共 6 条
[1]  
ALLEN E, 1997, THER DRUG MONIT TOXI, V18, P311
[2]   Topiramate - Safety and tolerability [J].
Jones, MW .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1998, 25 (03) :S13-S15
[3]   Topiramate - A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy [J].
Langtry, HD ;
Gillis, JC ;
Davis, R .
DRUGS, 1997, 54 (05) :752-773
[4]  
*MED EC CO INC, 1999, PHYS DESK REF, P2249
[5]   A pharmacological and clinical review on topiramate, a new antiepileptic drug [J].
Perucca, E .
PHARMACOLOGICAL RESEARCH, 1997, 35 (04) :241-256
[6]  
WOLF C, 1997, ANN M SOC FOR TOX SA